Content about Benzoates

October 10, 2013

Sales of Hyland’s oral analgesic products are up 23.5% to $15.4 million for the 52 weeks ended Aug. 11 across U.S. multi-outlets, according to IRI. Overall sales trends across the category are down by 1.7%, which suggests that what Hyland’s is doing is right — its products are safe, they work and they aren’t formulated with benzocaine.

Sales of Hyland’s oral analgesic products are up 23.5% to $15.4 million for the 52 weeks ended Aug. 11 across U.S. multi-outlets, according to IRI. Overall sales trends across the category are down by 1.7%, which suggests that what Hyland’s is doing is right — its products are safe, they work and they aren’t formulated with benzocaine.

September 6, 2013

The Food and Drug Administration has approved a drug made by Celgene for treating patients with pancreatic cancer that has spread to other parts of the body, the agency said Friday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a drug made by Celgene for treating patients with pancreatic cancer that has spread to other parts of the body, the agency said Friday.

The FDA announced the approval of Abraxane (paclitaxel protein-bound particles for injectable suspension, albumin-bound) for patients with late-stage forms of the disease. The drug is a chemotherapy treatment already approved for treating breast and lung cancers.

May 28, 2013

Soda may be as damaging to the teeth as some illegal drugs, according to a new study.

CHICAGO — Soda may be as damaging to the teeth as some illegal drugs, according to a new study.

The study, published in the March-April 2013 issue of the journal General Dentistry, found that drinking large quantities of carbonated soda that the study labeled "abusive" can be as harmful to dental health as methamphetamine and crack cocaine.

March 8, 2013

Last year the Food and Drug Administration warned parents against using the ingredient benzocaine in children to relieve oral pain.

SILVER SPRING, Md. — Last year the Food and Drug Administration warned parents against using the ingredient benzocaine in children to relieve oral pain. Children under the age of 2 years who are teething and given benzocaine should be under the supervision of a doctor, the agency warned.

September 28, 2012

Drug maker OncoGenex Pharmaceuticals has started its third late-stage clinical trial of a drug for treating a type of lung cancer.

BOTHELL, Wash. — Drug maker OncoGenex Pharmaceuticals has started its third late-stage clinical trial of a drug for treating a type of lung cancer.

OncoGenex announced Friday the initiation of the phase-3 "ENSPIRIT" trial of custirsen in patients with nonsmall cell lung cancer that has spread to other parts of the body, also known as metastasis, and whose disease has progressed after initial treatment with chemotherapy has failed.